
Teleflex Incorporated TFX
$ 104.64
-0.77%
Quarterly report 2025-Q3
added 11-06-2025
Teleflex Incorporated Total Liabilities 2011-2026 | TFX
Annual Total Liabilities Teleflex Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.82 B | 3.09 B | 2.91 B | 3.12 B | 3.82 B | 3.33 B | 3.74 B | 3.75 B | 1.75 B | 1.87 B | 2.06 B | 2.29 B | 1.96 B | 1.94 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.82 B | 1.75 B | 2.75 B |
Quarterly Total Liabilities Teleflex Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.05 B | 3.13 B | 3.07 B | 3 B | 2.88 B | 2.97 B | 3.18 B | 2.68 B | 2.81 B | 2.91 B | 2.86 B | - | 3.08 B | 3.12 B | 3.38 B | 3.6 B | 3.65 B | 3.82 B | 3.82 B | 3.82 B | 3.82 B | 3.33 B | 3.33 B | 3.33 B | 3.33 B | 3.74 B | 3.74 B | 3.74 B | 3.74 B | 3.75 B | 3.75 B | 3.75 B | 3.75 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 2.01 B | 2.06 B | 2.06 B | 2.06 B | 2.29 B | 2.29 B | 2.29 B | 2.29 B | 1.95 B | 1.96 B | 1.96 B | 1.96 B | 1.94 B | 1.94 B | 1.94 B | 1.94 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.05 B | 1.75 B | 2.79 B |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
18.8 B | $ 20.07 | 1.7 % | $ 10.2 B | ||
|
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
315 M | $ 150.64 | 0.41 % | $ 3.67 B | ||
|
Ekso Bionics Holdings
EKSO
|
13.9 M | $ 8.5 | 1.31 % | $ 171 M | ||
|
Alcon
ALC
|
8.79 B | $ 81.15 | 0.02 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
8.11 M | $ 5.47 | 0.37 % | $ 249 M | ||
|
AtriCure
ATRC
|
148 M | $ 37.09 | 0.38 % | $ 1.74 B | ||
|
Haemonetics Corporation
HAE
|
680 M | $ 66.22 | 0.38 % | $ 3.33 B | ||
|
electroCore
ECOR
|
8.66 M | $ 6.56 | -7.53 % | $ 36.2 K | ||
|
AngioDynamics
ANGO
|
97.2 M | $ 10.46 | 4.83 % | $ 427 M | ||
|
InfuSystem Holdings
INFU
|
51.4 M | $ 8.27 | 2.86 % | $ 171 M | ||
|
The Cooper Companies
COO
|
4.16 B | $ 81.14 | 0.96 % | $ 16.2 B | ||
|
Masimo Corporation
MASI
|
1.57 B | $ 136.3 | 0.04 % | $ 7.26 B | ||
|
Harvard Bioscience
HBIO
|
64.3 M | $ 0.51 | -4.57 % | $ 21.6 M | ||
|
OraSure Technologies
OSUR
|
69.3 M | $ 2.75 | -1.27 % | $ 205 M | ||
|
Glaukos Corporation
GKOS
|
479 M | $ 119.79 | 0.7 % | $ 5.8 B | ||
|
Merit Medical Systems
MMSI
|
1.04 B | $ 81.94 | 2.12 % | $ 4.77 B | ||
|
Isoray
ISR
|
50.4 M | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
841 M | $ 154.04 | 3.39 % | $ 4.81 B | ||
|
LeMaitre Vascular
LMAT
|
215 M | $ 84.67 | 0.97 % | $ 1.9 B | ||
|
Intuitive Surgical
ISRG
|
2.21 B | $ 504.38 | -0.62 % | $ 179 B | ||
|
STERIS plc
STE
|
3.53 B | $ 261.58 | -0.1 % | $ 25.8 B | ||
|
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
3.83 M | $ 1.82 | -2.15 % | $ 18.6 M | ||
|
Nephros
NEPH
|
3.5 M | $ 4.35 | -0.91 % | $ 45.2 M | ||
|
Utah Medical Products
UTMD
|
7.14 M | $ 61.22 | -0.71 % | $ 222 M | ||
|
Milestone Scientific
MLSS
|
3.96 M | $ 0.3 | 0.29 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
2.62 B | $ 23.26 | -0.47 % | $ 4.01 B | ||
|
Pro-Dex
PDEX
|
24.6 M | $ 38.97 | -1.1 % | $ 128 M | ||
|
Predictive Oncology
POAI
|
5.18 M | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
14.8 M | $ 13.8 | 1.32 % | $ 663 M | ||
|
Becton, Dickinson and Company
BDX
|
30.7 B | $ 203.51 | 1.21 % | $ 58.5 B | ||
|
Repligen Corporation
RGEN
|
866 M | $ 150.74 | -3.6 % | $ 8.4 M | ||
|
ResMed
RMD
|
1.74 B | $ 254.15 | -1.35 % | $ 37.1 B | ||
|
BioLife Solutions
BLFS
|
50.6 M | $ 21.9 | -3.01 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
20 M | $ 2.24 | -4.28 % | $ 181 M | ||
|
Retractable Technologies
RVP
|
73.6 M | $ 0.71 | -0.13 % | $ 21.3 M | ||
|
STAAR Surgical Company
STAA
|
112 M | $ 18.96 | 0.11 % | $ 931 M | ||
|
West Pharmaceutical Services
WST
|
961 M | $ 229.14 | -1.44 % | $ 16.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
3.81 B | $ 12.51 | 1.92 % | $ 2.54 B |